Health Care / Hospitals
Releases published in the last 30 days. 
Page 1 of 3
- Digital PCR Can Reliably Determine If Chronic Myeloid Leukemia Patients in Remission Can Successfully Discontinue Drug Treatment
- 3/28/2025 11:06:51 AM
- Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be discontinued.
- Second WHO Global Conference on Air Pollution and Health concludes with powerful commitments to protect public health
- 3/28/2025 10:41:38 AM
- The Second WHO Global Conference on Air Pollution and Health has concluded with major commitments from over 50 countries, cities and organizations ready to tackle air pollution and safeguard health.
- At least 14 million children face disruptions to critical nutrition services in 2025 – UNICEF
- 3/27/2025 10:48:31 AM
- At least 14 million children are expected to face disruptions to nutrition support and services because of recent and expected global funding cuts, leaving them at heightened risk of severe malnutrition and death – according to initial analyses issued by UNICEF as world leaders gather at the Nutrition for Growth Summit in Paris.
- AdvaMed® Congratulates Dr. Makary on his Confirmation as FDA Commissioner
- 3/27/2025 10:12:29 AM
- AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of the U.S.
- AMA applauds SCOTUS decision upholding the ATF’s regulation of ghost guns
- 3/27/2025 10:11:09 AM
- The following statement is attributable to: Bruce A. Scott, M.D. President, American Medical Association “We applaud the Supreme Court’s decision recognizing the authority of the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) in the regulation of ghost guns, which will help keep untraceable weapons out of the hands of dangerous criminals. “Ghost …
- Using LLMs to better understand autism diagnosis
- 3/26/2025 3:35:41 PM
- Most autism diagnoses are based on human intuition: medical professionals evaluate patients according to a specific set of criteria and provide their assessment.
- Author Patricia Hansen Unveils Her “Courageous Memoir, Bipolar Firsthand: My Journey From Hell and Depression to Peace and Self-Love”
- 3/26/2025 2:51:55 PM
- Acclaimed author Patricia Hansen delivers a powerful and unflinching look at the realities of living with bipolar disorder in her groundbreaking memoir, “Bipolar Firsthand: My Journey From Hell and Depression to Peace and Self-Love.” A raw, deeply personal, and ultimately inspiring account, this book sheds light on the struggles, triumphs, and self-discovery of a woman who …
- United Nations Decade of Action on Nutrition (2016–2025) extended to 2030
- 3/26/2025 11:00:15 AM
- On 24 March 2025, the United Nations General Assembly (UNGA) adopted a resolution to extend United Nations Decade of Action on Nutrition (the Nutrition Decade), originally from 2016–2025, to 2030.
- L’Oréal Announces Strategic Research Partnership with Tru Diagnostic to Advance Beauty and Longevity Science, through unlocking discoveries in Epigenomics.
- 3/26/2025 3:39:56 AM
- L’Oréal, the leader in the beauty industry, is thrilled to announce a strategic research and development partnership with Tru Diagnostic, the foremost authority in epigenomics(1) testing.
- Stewart Lonky, MD will Sign Copies of His Book “Outsmarting Obesity” at the 2025 L.A. Times Festival of Books
- 3/25/2025 1:03:31 PM
- Stewart Lonky, MD, will sign copies of his book “Outsmarting Obesity: A Doctor Reveals Why We Gain Weight, Why It Matters, and What We Can Do About It” at the 2025 Los Angeles Book Fair on April 26-27, 2025.
- Study Identifies Novel Pathway with Potential to Slow the Progression of Pulmonary Fibrosis
- 3/25/2025 9:17:06 AM
- Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical forces in tissues including stress, strain, and stiffness.
- OA Publisher Waiving APC for Researchers Due to Funding Cuts
- 3/25/2025 8:00:00 AM
- Partners in Digital Health recognizes the challenges researchers are facing due to recent funding cuts to NGOs and universities. To support the continuation of amplifying groundbreaking work in digital health, blockchain, AI, and emerging tech innovations for healthcare and life sciences, Partners in Digital Heath (PDH) is waiving the Article Processing Charge (APC) for ONE …
- Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
- 3/25/2025 4:36:59 AM
- Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL®, a recently approved CAR T therapy.
- AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
- 3/24/2025 10:01:32 AM
- AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China.
- Telehealth and Medicine Today and International Society for Telemedicine and eHealth Announce Strategic Collaboration to Advance Global Digital Health Innovation
- 3/24/2025 8:00:00 AM
- Telehealth and Medicine Today (THMT) and the International Society for Telemedicine and eHealth (ISfTeH) are pleased to announce a strategic collaboration aimed at accelerating the global education and adoption of digital health, telemedicine, and eHealth solutions.
- Housing market risks and stock market sell-off trigger slide in consumer outlook for middle- and upper-income Americans, clouding spending prospects—Bain/Dynata Consumer Health Indexes
- 3/24/2025 5:34:52 AM
- Back-to-back deteriorations in the outlook for American consumers’ future spending among both middle- and upper-income households since the end of last year indicate clouds continue to gather over US consumer prospects amid increased housing market risks and the stock market sell-off, according to the latest results of the Bain & Company/Dynata Consumer Health Indexes.
- Coronis Health Enhances Healthcare Delivery Systems through UiPath Platform
- 3/24/2025 5:26:43 AM
- UiPath (NYSE: PATH), a leading enterprise automation and AI software company, announced that Coronis Health, (Coronis) a leading provider of healthcare revenue cycle management (RCM) solutions, has leveraged the UiPath Platform™ to enhance their healthcare delivery systems.
- City of Hope Announces Tom Corson, Co-Chairman and COO, Warner Records, as 2025 Music, Film and Entertainment Industry Spirit of Life® Award Recipient
- 3/21/2025 12:41:41 PM
- City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top five in the nation for cancer by U.S.
- Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
- 3/21/2025 9:57:52 AM
- Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) • Phase III study showed sustained proteinuria reduction at one year with favorable safety 1 • Fabhalta is the only oral alternative complement pathway inhibitor thought to target the underlying cause of C3G 1-3 • …
- Nadine Evans Brought Her Eye-Opening Book to Help Women at the 2025 London Book Fair
- 3/20/2025 8:33:11 PM
- The self-publishing and book marketing company ReadersMagnet exhibited “Mastering the Monthly Madness: How Therapy Helps Ease the Mayhem of PMDD” by Nadine Evans at the 2025 London Book Fair.